German (DAX) Pharmaceuticals & Biotech Stocks - Biggest Losers Today

UPDATED Apr 18, 2024

Explore the German (DAX) Biggest Losers Today. These Pharmaceuticals & Biotech Stocks have seen the largest drop in Market Cap from the previous trading day.

35 companies
CompanyLast Price1D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

MRK

Merck KGaA
€146.75-0.3%-8.3%€63.8b€182.00PE22.6xE10.0%1.5%

1SXP

SCHOTT Pharma KGaA
€37.60-0.3%n/a€5.7b€38.48PE35.8xE15.5%0.4%

BAYN

Bayer
€26.24-0.04%-57.0%€25.8b€37.05PB0.8xE44.6%0.4%

FYB

Formycon
€39.70-1.2%-39.2%€701.1m€95.25PS10.2xE37.6%n/a

DMP

Dermapharm Holding
€31.80-0.5%-30.7%€1.7b€57.90PE27.5xE24.4%2.8%

HIGH

Cantourage Group
€7.60-3.8%-25.3%€94.8m€10.00n/aE19.0%n/a

93M1

MPH Health Care
€20.00-2.9%46.0%€88.2m€62.00PE1.7xE-22.0%0%

CNW

co.don
€0.24-29.0%-84.5%€6.5mn/aPB1xn/an/a

B8F

Biofrontera
€0.33-6.9%-73.9%€20.8mn/aPB1.5xn/an/a

APPH

Apontis Pharma
€8.24-1.2%-20.8%€68.6m€17.50PS1.9xE79.9%n/a

T5O

bioXXmed
€0.47-5.2%-79.2%€2.4mn/aPS117.7xn/an/a

SBH

Sangui Biotech International
€0.002-20.0%-66.7%€419.8kn/aPS4.7xn/an/a

BPXA

Bellicum Pharmaceuticals
€0.064-9.3%n/a€772.4kn/aPE-0.04xn/an/a

ECX

Epigenomics
€1.64-0.9%-46.0%€1.4m€16.85PS4.2xE102.5%n/a

MOR

MorphoSys
€67.700%269.8%€2.6b€58.71PS10.7xE51.0%n/a

991

Vitruvia Medical
€0.600%-70.0%€1.4mn/aPE-0.9xn/an/a

PA8K

Paion
€0.030%-99.5%€215.4k€8.70PE-0.01xE52.6%n/a

2FJ0

Pierrel
€1.690%-58.3%€92.8mn/aPE29.9xn/an/a

HPHA

Heidelberg Pharma
€2.960%-29.9%€138.0m€11.30PS14xS21.2%n/a

SBX

SynBiotic
€10.000%77.9%€46.8m€15.20PS5.7xE134.2%n/a

DBI

Deutsche Biotech Innovativ
€1.000%n/a€947.3kn/aPB1.4xn/an/a

CNW

co.don
€0.0130%-63.9%€347.4kn/an/an/an/a

3YX

INDVR Brands
€0.0020%0%€628.2kn/an/an/an/a

7V0

Darwin
€37.800%-0.5%€113.4mn/an/an/an/a
Page 1 of 2
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.